Navigating Insurance-Related Challenges Associated With MDS Treatment

Potential issues associated with insurance coverage and ways to navigate these challenges are discussed by medical experts.

EP: 1.Myelodysplastic Syndrome (MDS) Overview

EP: 2.Distinguishing Between Different MDS Subtypes

EP: 3.MDS-Related Complications Impacting Patient Quality of Life

EP: 4.Economic Implications of MDS Management

EP: 5.Examining Treatment Algorithms for MDS

EP: 6.Growth Factor and Stem Cell Transplant Candidacy in MDS

EP: 7.Novel Agents Contributing to Evolving MDS Therapy Strategies

EP: 8.Benefits of Oral Therapies In MDS Treatment Adherence

EP: 9.Adapting MDS Treatment Approach

EP: 10.Novel Therapy Impact on Patient Quality of Life

EP: 11.Multidisciplinary Care Driving Effective MDS Treatment

EP: 12.Payor Considerations In MDS Management

Now Viewing

EP: 13.Navigating Insurance-Related Challenges Associated With MDS Treatment

EP: 14.Key Considerations Surrounding MDS Treatment

Related Videos

Related Content

Advertisement

June 18th 2025

The Impact of High BMI on Outcomes, Treatment Efficacy in ALL

Laura Joszt, MA

High body mass index affects outcomes in acute lymphoblastic leukemia (ALL), highlighting the need for targeted interventions to improve patient survival rates and treatment efficacy.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

June 18th 2025

Defining On-Treatment Remission in Plaque Psoriasis

Pearl Steinzor

A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

June 18th 2025

Will Subcutaneous PD-1/PD-L1 Inhibitors Be a Game Changer?

Mary Caffrey

June 18th 2025

Dupilumab for Atopic Dermatitis May Increase Psoriasis Risk

Maggie L. Shaw

This study reveals that dupilumab is associated with a modestly increased risk of developing psoriasis, highlighting the importance of monitoring skin reactions during therapy.

Related Content

Advertisement

June 18th 2025

The Impact of High BMI on Outcomes, Treatment Efficacy in ALL

Laura Joszt, MA

High body mass index affects outcomes in acute lymphoblastic leukemia (ALL), highlighting the need for targeted interventions to improve patient survival rates and treatment efficacy.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

June 18th 2025

Defining On-Treatment Remission in Plaque Psoriasis

Pearl Steinzor

A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

June 18th 2025

Will Subcutaneous PD-1/PD-L1 Inhibitors Be a Game Changer?

Mary Caffrey

June 18th 2025

Dupilumab for Atopic Dermatitis May Increase Psoriasis Risk

Maggie L. Shaw

This study reveals that dupilumab is associated with a modestly increased risk of developing psoriasis, highlighting the importance of monitoring skin reactions during therapy.